Nivolumab With Ipilimumab Combined With TGFβ-15 Peptide Vaccine and Radiotherapy for Pancreatic Cancer (CheckVAC)

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-515966-14-00

Acronym

PA 2217

Enrollment

Registered

2024-09-13

Start date

2023-05-03

Completion date

Unknown

Last updated

2025-11-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

advanced pancreatic cancer

None listed

Sex/Gender

All

Age

18 Years to No maximum

Denmark

None listed

Source: EU CTIS · Data processed: Feb 4, 2026